Toward a biopsychosocial model for 21st-century genetics

Family Process

Volumn 44, Issue 1, 2005, Pages 3-24

  Rolland, John S ^a,c   Williams, Janet K ^b  

^a The University of Chicago   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; ARTICLE; BREAST TUMOR; CHILD; COMPARATIVE STUDY; FAMILY; FAMILY THERAPY; FEMALE; FORECASTING; GENETIC DISORDER; GENETIC SCREENING; GENETICS; HUMAN; HUNTINGTON CHOREA; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; SOCIAL ADAPTATION;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; FAMILY; FAMILY THERAPY; FEMALE; FORECASTING; GENETIC DISEASES, INBORN; GENETIC RESEARCH; GENETIC SCREENING; HUMANS; HUNTINGTON DISEASE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; SOCIAL ADJUSTMENT;

EID: 16244422307     PISSN: 00147370     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1545-5300.2005.00039.x     Document Type: Article

References (57)

1. Altschular, I., & McFadyen, A. (1999). Parental illness [Special Issue]. Journal of Family Therapy, 21:3.
2. Anderson, C., Reiss, D., & Hogarty, G. (1986). Schizophrenia and the family. New York: Guilford Press.
3. Babul, R., Adam, S., Kremer, B., Dufrasne, S., Wiggins, S., & Huggins, M. et al. (1993). Attitudes toward direct predictive testing for the Huntington's disease gene: Relevance for other adult-onset diseases. Journal of the American Medical Association, 270, 2321-2325.
4. Bateson, G. (1979). Mind and nature: A necessary unity. New York: Button.
5. Boss, P. (1999). Ambiguous loss: Learning to live with unresolved grief. Boston: Harvard University Press.
6. Brouwer-DudokdeWit, A.C., Savenije, A., Zoeteweij, M., Maat-Kievit, A., & Tibben, A. (2002). A hereditary disorder in the family and the family life cycle: Huntington disease as a paradigm. Family Process, 41, 677-692.
7. Burke, W., Pinsky, L., & Press, N. (2001). Categorizing genetic tests to identify their ethical, legal, and social implications, American Journal of Medical Genetics, 106, 233-240.
8. Campion, D., Dumanchin, C., & Hannequin, D., Dubois, B., Belliard, S., Puel, M. et al. (1999). Early-onset Alzheimer autosomal dominant disease: Prevalence, genetic heterogeneity, and mutation spectrum. American Journal of Human Genetics, 65, 664-670.
9. Carter, E.A., & McGoldrick, M. (Eds.). (1999). The evolving family life cycle: Individual, family, and social perspectives (3rd ed.). New York: Allyn & Bacon.
10. Collins, F.S., Green, E., Guttmacher, A.E., & Guyer, M.S. (2003). A vision for the future of genomic research. Nature, 422, 835-847.
11. Duvoisin, R.C. (1996). Recent advances in the genetics of Parkinson's disease. Advances in Neurology, 69, 33-40.
12. Engel, G.L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196, 129-136.
13. Golub, T.R. (2001). Genomic approaches to the pathogenesis of hematologic malignancy. Current Opinions in Hematology, 8, 252-261.
14. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., & Mesirov, J.P. et al. (1999). Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.
15. Gonzalez, S., & Steinglass, P. (2002). Application of multifamily groups in chronic medical disorders. In W.F. McFarlane (Ed.), Multifamily groups in the treatment of severe psychiatric disorders, (pp. 315-341). New York: Guilford Press.
16. Kessler, S., & Bloch, M. (1989). Social system responses to Huntington disease. Family Process, 28, 59-68.
17. Kuusisto, J., Koivisto, K., & Kervinen, K., Mykkanen, L., Helkala, E-L., Vanhanen, N. et al. (1994). Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. British Medical Journal, 309, 636-638.
18. Levinson, D.J. (1986). A conception of adult development. American Psychologist, 41, 3-13.
19. Lynch, H.T., & de la Chapelle, A. (2003). Genomic medicine: Hereditary colorectal cancer. New England Journal of Medicine, 348, 919-932.
20. nd ed). New York: Springer-Verlag.
21. McFarlane, W.F. (Ed.) (2002). Multifamily groups in the treatment of severe psychiatric disorders. New York: Guilford Press.
22. McGuffin, P., Owen, M.J., & Gottesman, I. (2002). Psychiatric genetics and genomics. Oxford, UK: Oxford University Press.
23. Miller, S., McDaniel, S., Rolland, J., & Feetham, S. (Eds.) (in press). Individuals, families, and the new era of genetics: Biopsychosocial perspectives. New York: W.W. Norton.
24. Nussbaum, R.L., & Ellis, C.E. (2003). Genomic medicine: Alzheimer's disease and Parkinson's disease. New England Journal of Medicine, 348, 1356-1364.
25. Quaid, K., & Morris, M. (1993). Reluctance to undergo predictive testing by those at risk for Huntington's disease. American Journal of Medical Genetics, 45, 41-45.
26. Patenaude, A.F., Guttmacher, A., & Collins, F. (2002). Genetic testing and psychology: New roles, new responsibilities. American Psychologist, 57, 271-282.
27. Patterson, J.M. (1988). Chronic illness in children and the impact on families. In C.S. Chilman, E.W. Nunnally, & F.M. Cox (Eds.), Chronic illness and disability. Families in Trouble Series, Vol. 2. Newbury Park, CA: Sage.
28. th century. Family Process, 41, 135-157.
29. Plomin, R., Defries, J.C., McClearn, G.E., & McGuffin, F. (2000). Behavioral genetics. London: W.H. Freeman.
30. Polymeropoulos, M.H., Lavedan, C., & Leroy, E., Ide, S. E., Dehegia, A., Dutra, A. et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
31. nd ed., pp. 406-413). New York: W.W. Norton.
32. Reiss, D., Neierhiser, J., Hetherington, M., & Plomin, R. (2000). The relationship code: Deciphering genetic and social influence on adolescent development. Cambridge, MA: University Harvard Press.
33. Rolland, J.S. (1984). Toward a psychosocial typology of chronic and life-threatening illness. Family Systems Medicine, 2, 245-263.
34. Rolland, J.S. (1987). Chronic illness and the life cycle: A conceptual framework. Family Process, 26, 203-221.
35. Rolland, J.S. (1990). Anticipatory loss: A family systems developmental framework. Family Process, 29, 229-244.
36. Rolland, J.S. (1994a). Families, illness, & disability: An integrative treatment model. New York: Basic Books.
37. Rolland, J.S. (1994b). In sickness and in health: The impact of illness on couples' relationships. Journal of Marital and Family Therapy, 20, 327-349.
38. Rolland, J.S. (1998). Beliefs and collaboration: Evolution over time. Families, Systems, & Health, 16, 7-25.
39. Rolland, J.S. (1999). Families and genetic fate: A millennial challenge. Families, Systems, & Health, 17, 123-133.
40. rd ed., pp. 460-489). New York: Guilford Press.
41. nd ed., pp. 213-237). New York: W.W. Norton.
42. Rolland, J.S. (under review). Genetics and anticipatory loss: A family systems developmental framework.
43. Rolland, J.S., & McDaniel, S.H. (in press). Beliefs and multicultural issues in the new era of genetics. In S. Miller, S. McDaniel, J. Rolland, & S. Feetham (Eds.), Individuals, families, and the new era of genetics: Biopsychosocial perspectives. New York: W.W. Norton.
44. Roses, A.D. (1996). Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annual Review of Medicine, 47, 387-400.
45. Seaburn, D., Gunn, W., Mauksch, L., Gawinski, A., & Lorenz, A. (Eds.). (1996). Models of collaboration: A guide for mental health professionals working with physicians and health care providers. New York: Basic Books.
46. Secretary's Advisory Committee on Genetic Testing. National Institutes of Health. A public consultation of oversight of genetic tests. Retrieved January 31, 2000, from http://www4od.nih.gov/oba/sacgt.html.
47. Sobel, S., & Cowan, C. B. (2003). Ambiguous loss and disenfranchised grief: The impact of DNA predictive testing on the family as a system. Family Process, 42, 47-59.
48. Steinglass, P. (1998). Multiple family discussion groups for patients with chronic medical illness. Families, Systems, & Health, 16, 55-71.
49. Street, E., & Soldan, J. (1998). A conceptual framework for the psychosocial issues faced by families with genetic conditions. Families, Systems, & Health, 16, 217-233.
50. Taswell, H., & Sholtes, S. (1999). Predictive genetic testing: A story of one family. Families, Systems, & Health, 17, 111-123.
51. Tienari, P., Wynne, L.C., Sorri, A., Lahti, I., Laksy, K., & Moring, J. et al. (2004). Genotype-environment interaction in schizophrenia-spectrum disorder: Long-term follow-up study of Finnish adoptees. British Journal of Psychiatry, 184, 216-222.
52. Wagner, K.R. (2002). Genetic disease of muscle. Neurological Clinics, 20, 645-678.
53. Walsh, F. (1998). Strengthening family resilience. New York: Guilford Press.
54. rd ed., pp. 3-26). New York: Guilford Press.
55. Williams, J.K., Schutte, D.L., Evers, C., & Holkup, P.A. (2000). Redefinition: Coping with normal results from predictive gene testing for neurodegenerative disorders. Research in Nursing & Health, 23, 260-269.
56. Williams, J.K., Schutte, D.L., Holkup, P.A., Evers, C., & Muilenburg, A. (2000). Psychosocial impact of predictive testing for Huntington disease on support persons. American Journal of Medical Genetics (Neuropsychiatric Genetics), 96, 353-359.
57. Wooster, R., & Weber, B.L. (2003). Genomic medicine: Breast and ovarian cancer. New England Journal of Medicine, 348, 2339-2347.